Information  X 
Enter a valid email address

Danakali Limited (DNK)

  Print      Mail a friend

Thursday 20 February, 2020

Danakali Limited

Change of Director's Interest Notice

RNS Number : 5273D
Danakali Limited
20 February 2020
 

Rule 3.19A.2

Appendix 3Y

 

Change of Director's Interest Notice

 

Information or documents not available now must be given to ASX as soon as available.  Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01  Amended 01/01/11

 

Name of entity  DANAKALI LTD

ABN  56 097 904 302

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. 

 

Name of Director

Seamus Ian Cornelius

Date of last notice

14 June 2019

 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

 

Direct or indirect interest

(a)  Direct

(b)  Indirect

(c)  Indirect

(d)  Indirect

 

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

(b)  Kongming Investments Ltd - Director of the Company

(c)  Sino West Assets Ltd - Director of the Company

(d)  Seamus Ignatius Quan Cornelius - Son of Seamus Ian Cornelius

 

Date of change

19 February 2020

No. of securities held prior to change

Direct Holding

(a)  4,831,664 fully paid ordinary shares

 

(a)  300,000 unlisted options (remuneration) at $0.94, expiring on 19/05/2020

 

Indirect Holding

(b)  4,178,992 fully paid ordinary shares

 

  (c)  1,318,309 fully paid ordinary shares

 

  (d)  301,040 unlisted options (remuneration) at $1.031, expiring on 24/01/2022

 

Class

Ordinary shares

 

Number acquired

62,960

 

Number disposed

Nil

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

$35,716.91

 

 

No. of securities held after change

Direct Holding

(a)  4,894,624 fully paid ordinary shares

 

(a)  300,000 unlisted options (remuneration) at $0.94, expiring on 19/05/2020

 

Indirect Holding

(b)  4,178,992 fully paid ordinary shares

 

 (c)  1,318,309 fully paid ordinary shares

 

  (d)  301,040 unlisted options (remuneration) at $1.031, expiring on 24/01/2022

 

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

On market purchase.

 

 

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

N/A

Nature of interest

N/A

Name of registered holder

(if issued securities)

N/A

Date of change

N/A

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

 

N/A

Interest acquired

N/A

Interest disposed

N/A

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

 

N/A

Interest after change

N/A

 

Part 3 - + Closed period

Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

N/A

If prior written clearance was provided, on what date was this provided?

N/A

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHSFFFWUESSEIE

a d v e r t i s e m e n t